Croda Healthcare gains certificate

Published: 2-Mar-2002


Croda Healthcare, the pharmaceutical and nutritional division of Croda Oleochemicals, has been awarded a Certificate of Suitability for the manufacture of Omega-3 Acid Triglycerides (Incromega TG3322). This certificate, from the European Directorate for the Quality of Medicines, ensures product compliance with the European Pharmacopoeia. It is also a guarantee of product quality for companies seeking actives or excipients for pharmaceuticals.

Croda's speciality lipid plant located at Leek in the UK, operates to the principles of GMP, producing high purity marine and plant lipids for pharmaceutical and nutritional markets. Omega-3 fish oils have been indicated in the treatment of various disorders such as cardiovascular diseases, hypertension, hyperlipidemia and hypertriglyceridemia, inflammatory and autoimmune diseases, cognitive disorders, and various cancers.

You may also like